SCHEDULE: Artisan Partners Discloses 7.0% Stake in DBV Technologies
Beneficial Ownership Report
Artisan Partners Asset Management Inc. and its affiliates have reported a 7.0% beneficial ownership stake in DBV Technologies S.A. American Depositary Shares.
Summary
- Artisan Partners Asset Management Inc., along with its affiliates Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership, collectively beneficially own 3,309,055 American Depositary Shares of DBV Technologies S.A.
- This ownership represents 7.0% of DBV Technologies S.A.'s outstanding class of securities, based on 47,134,173 shares outstanding as of December 31, 2025.
- The reporting persons have shared voting power over 2,976,900 shares and shared dispositive power over all 3,309,055 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of DBV Technologies S.A.
- Artisan Partners Limited Partnership, an investment adviser, acquired these shares on behalf of its discretionary clients, with no single client holding an economic interest exceeding 5% of the class.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development. The disclosure of a significant passive stake by a reputable institutional investor like Artisan Partners typically signals confidence in the issuer's long-term value, without implying immediate operational changes or activist pressure.
Positives
- A significant institutional investor, Artisan Partners, has taken a 7.0% stake, which can be viewed as a vote of confidence in DBV Technologies S.A.'s long-term prospects.
- The filing indicates the shares are held in the ordinary course of business, suggesting a passive investment strategy rather than an activist one, which can provide stability.
Negatives
- NA
Risks
- NA
Future Outlook
This Schedule 13G filing does not contain any forward-looking statements or guidance regarding DBV Technologies S.A.'s future financial performance or strategic direction.
Management Comments
- Gregory K. Ramirez, Executive Vice President of Artisan Partners Asset Management Inc., certified that the securities were acquired and are held in the ordinary course of business and not for the purpose or with the effect of changing or influencing the control of DBV Technologies S.A.
Industry Context
StockSavvy.ai notes that a 7.0% stake by a prominent asset manager like Artisan Partners in a biotechnology company such as DBV Technologies S.A. is a notable institutional endorsement. Such filings often signal that large funds see long-term value or potential in the company, aligning with broader trends of institutional capital flowing into specialized biotech firms.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: The presence of a significant institutional investor like Artisan Partners can provide a degree of stability and validation for other shareholders, potentially attracting further institutional interest.
- Company Management: Management may view this as a positive signal of investor confidence, though it does not imply any direct influence on company operations or strategy given the passive nature of the filing.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of event which requires the filing of this statement, indicating the reporting period end for the ownership stake. |
| 02/03/2026 | Date the Schedule 13G filing was signed and submitted. |
Recommendation
holdThis filing indicates a significant institutional investment, which is generally a positive signal of confidence. However, a Schedule 13G is a passive ownership disclosure and does not provide new operational or financial data about DBV Technologies S.A. to warrant a 'buy' or 'sell' recommendation. It primarily confirms institutional interest. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while awaiting further operational or financial updates from the company.
Keywords
DBV Technologies, Artisan Partners, Beneficial Ownership, SEC Filing, Schedule 13G, American Depositary Shares, Institutional Investment, Biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.